Merck Clears €10 Billion Bio-Techne Deal with German Competition Authority

Merck's €10 billion takeover of US biotechnology company Bio-Techne has been cleared by Germany's competition authority. The watchdog stated that there was limited competition between the companies' products, leading to a relatively smooth approval process.

The deal, which was first announced earlier this year, will give Merck a significant boost in its biotech division. However, the watchdog noted that where there were overlaps in product offerings, measures would be put in place to ensure fair competition remains.